Serena Williams has revealed that she's taking a GLP-1 injectable weight loss treatment, in addition to her health regimen.

Glucagon-like peptide-1 (GLP-1) receptor agonists show promise in reducing cancer risk among patients with obesity, particularly for endometrial, ovarian, and meningioma cancers.

Serena Williams revealed how she turned her health around with the help of a GLP-1 medication after she struggled to lose ...

According to the Cleaveland Clinic, GLP-1 agonists (glucagon-like peptide-1 receptor agonists) are injectable medications ...

Tennis legend Serena Williams has sparked conversations around fitness and health after reports of her weight loss journey ...

“Semaglutide has been in the US for more than eight years now. In India also, the oral version of this molecule is there for ...

Serena Williams revealed she uses GLP-1 medication to aid weight loss after motherhood. This highlights a shift towards combining medicine with lifestyle for obesity management.

Serena Williams, the tennis legend with 23 Grand Slam singles titles, has always been admired for her athletic prowess and ...

Researchers have developed fluorescent probes, daLUXendins, to track dual agonist drugs like tirzepatide in live tissues. The ...

Serena Williams reveals she has been using GLP-1 medications for weight loss, shedding 31 pounds. The tennis star highlights its benefits on her health.

Tennis legend Serena Williams, 43, has explained how she has managed to shed a remarkable 31 pounds over the past 18 months ...

"This retrospective cohort study found that taking GLP-1RAs was associated with a reduced overall risk of cancer, including lower risks of endometrial, ovarian, and meningioma cancers, among patients ...